LAUREN PRIOR: Open Payments
NPI 1659051704 · MIDDLETOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 59 payments from 17 companies in 2025. Trend: 2023 $120 · 2024 $1,417 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $267 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $227 |
| Ardelyx, Inc. | 8 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $112 |
| QOL Medical, LLC | 3 | $106 |
| Janssen Biotech, Inc. | 4 | $79 |
| Ethicon US, LLC | 1 | $73 |
| Madrigal Pharmaceuticals | 2 | $49 |
| PFIZER INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $43 |
Products named: XIFAXAN, IBSRELA, ENTYVIO, Sucraid, SKYRIZI, TREMFYA, LINX REFLUX MANAGEMENT SYSTEM, RINVOQ.
Industry payments across CT — which companies pay providers there.
